brain neoplasm: A neoplasm (disease) that involves the brain.
Melanocytic naevi of upper limb, including shoulder
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_MELANOCYTIC_UPPERLIMB
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
898 |
4. Check minimum number of eventsNone |
898 |
5. Include endpointsNone |
898 |
6. Filter based on genotype QC (FinnGen only) |
864 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5751 | 3429 | 2304 |
| Only index persons | 5400 | 3265 | 2135 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.06 |
| Only index persons | 0.10 | 0.12 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 41.00 | 39.84 | 42.75 |
| Only index persons | 41.93 | 40.42 | 44.24 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 864 | 564 | 300 |
| Unadjusted period prevalence (%) | 0.18 | 0.20 | 0.14 |
| Median age at first event (years) | 53.28 | 48.38 | 62.51 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 898
- Matched controls
- 8980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
66.6
307.7
317
73
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
4671.7
307.7
857
40
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
12.1
265.5
331
413
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
13.3
251.5
280
296
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
10.1
173.8
228
294
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
12.2
111.9
118
110
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.8
109.3
170
262
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
15.0
100.3
92
68
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
26.2
96.9
68
28
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.3
96.7
189
367
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
7.2
92.4
151
244
L57.0
ICD-10 Finland
Actinic keratosis
5.5
89.7
203
450
XQ845
NOMESCO Finland
Dermatoscopy
14.3
73.2
68
51
XQ848
NOMESCO Finland
Dermatological photography
9.4
70.0
87
101
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
10.3
67.5
78
82
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
12.5
61.6
62
53
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
19.2
55.5
44
24
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
7.7
54.6
80
113
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
5.1
52.0
120
265
ZXC50
NOMESCO Finland
Cryotherapy
7.9
50.3
71
96
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.2
50.1
268
1065
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.0
46.4
54
57
TQW99
NOMESCO Finland
Other minor procedure on skin
5.3
44.1
94
193
2166A
ICD-9 Finland
Benign neoplasm of skin, Skin of upper limb, including shoulder[YLÄRAAJAN IHON BEN KASV,NAEVUS PIGMENTOSUS]
+∞
43.1
41
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
8.6
41.8
55
68
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
139.4
38.0
40
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
13.8
34.1
32
24
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
12.7
32.5
32
26
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
12.8
31.6
31
25
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
33.0
31.5
41
13
L82
ICD-10 Finland
Seborrhoeic keratosis
2.6
29.8
208
924
127
Kela drug reimbursment
Transplant complication
8.9
29.4
37
43
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
29.0
29.1
39
14
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
7.4
28.6
42
59
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.7
27.9
45
70
PJA12
NOMESCO Finland
Sentinel node biopsy
3.3
27.3
115
387
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.9
27.0
83
227
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
32.1
26.1
34
11
9733
FHL
Excision of skin change in operating room or anesthesia
7.2
25.2
38
55
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
25.2
24.5
34
14
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
37.4
23.1
29
8
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
53.5
22.2
26
5
ZZR00
NOMESCO Finland
Flap of skin
6.4
22.1
37
60
L04AA06
ATC
mycophenolic acid; systemic
6.9
21.8
34
51
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
82.2
21.8
24
*
S82
ICPC
Naevus/mole
2.4
20.6
162
751
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.3
20.2
41
80
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
21.4
20.0
29
14
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
6.3
19.0
32
52
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
19.2
18.7
28
15
Z2221
NOMESCO Finland
Medical doctor
2.0
18.7
284
1700
S18
ICPC
Laceration/cut
1.9
18.5
432
2974
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
15.5
18.5
30
20
TQW80
NOMESCO Finland
Local dermatologic skincare
4.9
17.7
39
82
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.7
17.6
28
43
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
29.5
17.5
23
8
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
28.1
16.6
22
8
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
4.6
16.5
40
91
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
12.5
15.9
28
23
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
19.6
15.6
23
12
D06BB10
ATC
imiquimod; topical
3.1
15.5
67
228
ZQZ00
NOMESCO Finland
Treatment of several skin areas
23.9
15.2
21
9
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
5.8
14.7
27
48
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
11.1
14.1
26
24
D03.5
ICD-10 Finland
Melanoma in situ of trunk
16.1
14.0
22
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
13.9
68
248
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
5.2
13.7
28
55
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
18.6
13.4
20
11
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
6.4
13.3
22
35
Z94.0
ICD-10 Finland
Kidney transplant status
9.9
13.3
26
27
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
19.4
12.9
19
10
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
3.3
12.9
48
149
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
12.8
340
2361
TK800
NOMESCO Finland
Hemodialysis
4.9
12.7
28
59
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
20.4
12.5
18
9
C43
ICD-10 Finland
Malignant melanoma of skin
21.6
12.0
17
8
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
12.0
28
62
S21
ICPC
Skin texture symptom/complaint
2.0
11.4
136
735
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.5
11.3
27
61
L04AD01
ATC
ciclosporin; systemic
4.7
11.2
26
57
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
12.9
11.2
19
15
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
10.2
11.0
21
21
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
43.9
10.9
13
*
180
Kela drug reimbursment
Interferon alfa
18.1
10.7
16
9
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
111.3
10.4
11
*
B07.9
ICD-10 Finland
Verruca simplex
3.1
10.4
43
143
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
7.6
10.2
23
31
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
5.4
10.1
20
38
E0000UV, ,
ATC
1.6
9.9
371
2764
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.8
9.8
18
17
D22
ICD-10 Finland
Melanocytic naevi
2.6
9.6
57
230
S77
ICPC
Malignant neoplasm of skin
7.7
9.4
21
28
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
17.8
9.4
14
8
J01DB01
ATC
cefalexin; oral
1.7
9.4
730
6416
A12AA04
ATC
calcium carbonate; oral
5.0
9.3
20
41
L91.0
ICD-10 Finland
Hypertrophic scar
4.6
9.3
22
49
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
8.8
55
228
SPAT1153
SPAT
Removal of sutures
1.6
8.7
263
1851
L04AA01
ATC
[U] ciclosporin
6.7
8.7
21
32
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
11.7
8.6
15
13
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
4.1
8.6
23
57
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.3
8.6
32
100
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
27.8
8.5
11
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
20.2
8.5
12
6
4056, ,
NOMESCO Finland
+∞
8.3
8
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
11.8
8.1
14
12
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.4
8.0
20
32
L04AD02
ATC
tacrolimus; systemic
7.3
8.0
18
25
ZXC20
NOMESCO Finland
Use of chemical agents
3.8
7.9
24
65
R4110
NOMESCO Finland
Physiotherapy
1.6
7.9
228
1583
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
8.6
7.8
16
19
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
9.5
7.8
15
16
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
7.8
44
174
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
45.4
7.7
9
*
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
45.4
7.7
9
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
7.7
45
181
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.8
7.6
18
27
Z3231
NOMESCO Finland
Registered nurse
1.6
7.6
231
1621
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
25.2
7.6
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
7.5
113
657
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
13.5
7.4
12
9
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
7.3
7
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
+∞
7.3
7
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
6.3
7.3
18
29
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
7.1
30
101
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
12.1
7.1
12
10
L04AX01
ATC
azathioprine; systemic
2.5
7.0
42
171
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
3.3
7.0
26
81
A11CC03
ATC
alfacalcidol; systemic
3.4
7.0
25
76
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
7.0
48
209
S29
ICPC
Skin symptom/complaint other
1.6
6.9
159
1041
ZXA00
NOMESCO Finland
Right side
1.6
6.8
209
1466
L03AB05
ATC
interferon alfa-2b; parenteral
16.8
6.8
10
6
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.9
6.7
31
110
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.4
6.7
23
68
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
3.3
6.6
24
74
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
6.5
290
2195
H02AB09
ATC
hydrocortisone; systemic
3.3
6.5
24
75
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.4
6.4
44
191
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
70.3
6.4
7
*
XW000
NOMESCO Finland
Bone marrow biopsy
2.6
6.4
37
148
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
14.4
6.4
10
7
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.6
6.4
15
23
C44
ICD-10 Finland
Other malignant neoplasms of skin
18.2
6.3
9
5
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.2
350
2765
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.0
6.2
17
43
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
5.4
6.2
17
32
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.6
6.1
33
128
QCA10
NOMESCO Finland
Incision of skin of upper limb
12.6
6.1
10
8
TQW40, ,
SPAT
2.0
6.1
62
317
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
28
44
6.54
17.18
1.8
1.5
14.58
7.00
ug/l
0.50
28
34
545
4304
1.68
12.41
11.8
8.7
3.80
4.06
e9/l
2.37
479
3774
394
2960
1.59
10.23
6.6
4.6
35.85
35.91
g/l
0.07
367
2778
461
3604
1.57
10.01
8.2
5.8
28.63
28.41
%
0.16
441
3389
468
3689
1.56
9.67
7.2
5.9
10.93
10.97
umol/l
0.04
450
3497
279
1951
1.62
9.65
3.6
2.9
0.22
0.44
e6/l
2.33
207
1450
100
514
2.06
9.62
4.8
3.9
95.88
80.00
ng/l
0.95
90
463
746
6606
1.76
9.22
20.5
15.6
14.31
14.67
%
1.35
738
6501
436
3420
1.53
8.96
9.4
6.6
1.21
1.21
mmol/l
0.04
373
2916
296
2154
1.56
8.43
3.7
3.0
225.37
91.20
e6/l
0.34
224
1631
448
3572
1.51
8.30
8.1
5.6
56.28
56.95
%
0.57
429
3358
643
5541
1.57
8.20
9.6
7.1
77.35
78.04
u/l
0.09
615
5215
253
1792
1.57
8.05
4.8
3.7
92.28
92.59
%
0.07
248
1745
92
491
1.97
7.97
3.0
3.0
195.05
193.77
ng/l
0.01
83
443
177
1158
1.66
7.78
2.7
2.6
0.98
1.09
e6/l
0.11
99
631
14
14
10.14
7.55
1.0
2.0
1.07
2.18
ug/l
—
6
6
455
3703
1.46
7.23
5.0
4.8
0.00
0.00
estimate
0.50
89
746
246
1780
1.53
6.97
3.1
2.6
6459.77
6044.64
umol/l
0.04
222
1572
607
5245
1.49
6.95
3.4
3.3
—
—
—
0
0
576
4927
1.47
6.94
4.8
4.3
24.88
2533.55
e6/l
—
8
75
457
3749
1.45
6.81
3.7
3.5
0.00
0.00
estimate
0.50
90
718
451
3698
1.44
6.70
3.8
3.5
0.00
0.00
estimate
0.50
95
783
211
1496
1.54
6.52
3.2
2.5
3.50
6.75
e6/l
4.42
188
1326
381
3053
1.43
6.29
2.6
2.3
77.16
75.96
nmol/l
0.34
364
2742
387
3112
1.43
6.26
8.0
5.9
1.21
1.21
mmol/l
0.33
363
2846
34
134
2.60
6.09
3.2
3.6
4.54
4.36
e9/l
0.16
34
134
35
140
2.56
6.09
7.8
5.7
328.25
317.00
iu/ml
—
8
18
35
140
2.56
6.09
3.6
4.0
61.26
56.87
%
1.25
35
140
161
1099
1.57
5.85
2.9
2.7
2.92
3.02
e6/l
0.04
82
579
804
7480
1.72
5.79
16.5
12.9
21.87
22.57
mg/l
0.22
633
5875
126
820
1.62
5.58
3.4
2.7
8.87
7.90
umol/l
0.22
115
706
424
3528
1.38
5.35
3.0
2.5
—
—
—
0
0
615
5459
1.40
5.13
4.8
3.9
10.60
11.36
mm/h
0.76
572
5054
306
2432
1.39
5.02
3.8
3.1
27.78
31.49
u/l
1.98
294
2319
54
284
1.96
4.93
1.7
2.0
1.37
1.52
g/l
0.70
46
250
97
622
1.63
4.56
4.8
3.9
1.33
1.85
mmol/l
0.66
82
502
113
753
1.57
4.53
1.9
1.8
—
—
—
0
0
649
5877
1.38
4.35
4.3
4.0
14.71
14.61
pmol/l
0.49
606
5375
829
7876
1.68
4.23
12.4
9.7
25.03
25.81
u/l
0.74
809
7621
44
230
1.96
4.13
3.0
2.5
3.41
3.66
g/l
0.61
44
219
99
655
1.57
4.10
2.2
2.3
33.98
33.77
u/l
0.02
87
549
256
2037
1.36
4.02
2.3
2.0
240.39
243.00
u/l
0.01
240
1918
58
335
1.78
4.01
5.8
4.3
23.87
24.03
mmol/l
0.11
58
327
53
299
1.82
3.96
1.5
1.4
—
—
—
0
0
151
1101
1.45
3.94
5.5
3.5
0.81
0.82
mmol/l
0.13
140
1040
153
1119
1.44
3.93
3.2
2.3
13.03
13.27
umol/l
0.16
148
1037
132
941
1.47
3.87
3.4
2.4
22.20
22.77
%
0.20
117
812
147
1070
1.45
3.87
2.5
2.0
29.44
29.61
s
0.18
141
1039
866
8359
2.01
3.81
25.4
19.1
250.90
253.38
e9/l
0.54
858
8174
109
750
1.52
3.80
1.9
1.7
—
—
—
0
0
292
2388
1.33
3.78
4.4
3.3
2.35
2.35
mmol/l
0.52
262
2121
866
8363
2.00
3.74
25.4
19.1
4.48
4.49
e12/l
0.40
856
8158
213
1664
1.37
3.73
2.0
1.7
2.32
1.15
mg/l
0.70
164
1261
140
1018
1.44
3.71
3.3
2.3
2.30
2.35
g/l
0.57
135
941
34
169
2.05
3.69
2.1
1.7
38.27
779.14
e6/l
0.59
26
135
34
169
2.05
3.69
2.1
1.6
7.08
9.81
e6/l
0.19
26
130
39
204
1.95
3.68
8.5
4.8
1.69
1.45
mg/l
0.89
39
186
792
7495
1.48
3.55
19.2
14.6
139.67
139.65
mmol/l
0.12
778
7296
742
6946
1.39
3.48
5.2
4.7
1.87
2.04
mu/l
0.48
706
6415
333
2801
1.30
3.46
2.0
1.9
96.76
95.06
pmol/l
0.29
179
1489
75
485
1.60
3.45
1.6
1.6
—
—
—
0
0
166
1266
1.38
3.35
3.3
2.9
2.45
2.44
mmol/l
0.35
144
1121
8
14
5.75
3.34
1.0
1.5
—
—
—
0
0
40
219
1.87
3.32
1.8
2.6
9.99
10.61
g/l
0.36
40
201
166
1271
1.38
3.27
4.0
3.6
383.46
431.66
ng/l
0.09
123
924
792
7519
1.45
3.24
19.4
14.6
3.94
3.95
mmol/l
0.49
778
7304
863
8354
1.85
3.24
25.4
19.1
39.94
40.14
%
0.45
808
7867
102
726
1.46
3.03
5.8
8.3
0.96
1.14
mmol/l
0.20
79
579
471
4188
1.26
3.00
5.1
4.7
6.40
6.60
mmol/l
1.53
442
3874
42
242
1.77
2.99
1.9
2.5
—
—
—
0
0
42
242
1.77
2.99
1.9
2.5
6.73
7.32
g/l
1.64
42
225
42
242
1.77
2.99
1.9
2.5
3.41
3.65
g/l
0.80
42
225
749
7065
1.36
2.99
4.6
4.2
5.81
5.85
mmol/l
0.40
709
6485
219
1771
1.31
2.98
2.7
2.2
—
—
—
0
0
40
228
1.79
2.95
1.9
2.5
2.75
2.95
g/l
0.75
40
211
142
1079
1.38
2.93
2.0
1.8
—
—
—
0
0
45
267
1.72
2.91
1.6
1.8
—
—
—
0
0
6
9
6.70
2.87
3.2
3.8
—
—
—
0
0
204
1643
1.31
2.85
1.5
1.5
20.54
20.73
nmol/l
0.07
186
1396
131
987
1.38
2.84
2.4
2.5
124.48
113.98
ug/g
0.14
109
775
18
77
2.37
2.83
1.0
1.1
—
—
—
0
0
136
1032
1.37
2.83
3.2
3.0
0.62
0.74
ug/l
1.79
103
679
51
316
1.65
2.82
1.5
2.1
39.22
39.93
u/l
0.08
46
284
63
414
1.56
2.75
6.2
9.2
1.22
1.40
%
1.13
63
409
37
213
1.77
2.67
2.1
2.7
1.05
0.81
g/l
0.13
32
193
79
550
1.48
2.65
2.8
2.6
58.03
68.78
ml/min/173m2
1.56
35
232
33
185
1.81
2.60
4.5
3.9
29.15
46.20
mg/l
0.51
25
149
33
185
1.81
2.60
4.6
3.9
67.48
89.71
mg/l
0.25
25
148
75
522
1.48
2.53
2.3
2.3
38.23
22.14
au/ml
—
6
40
264
2230
1.26
2.52
3.2
2.4
69.74
94.70
u/l
0.29
249
2064
34
195
1.77
2.50
1.7
2.7
37.96
37.77
g/l
0.07
34
178
25
130
1.95
2.47
1.4
1.5
—
—
—
0
0
61
410
1.52
2.43
6.2
9.3
0.67
0.69
%
0.27
61
405
32
182
1.79
2.42
4.6
3.8
—
1.99
—
0
21
178
1439
1.30
2.41
4.9
4.4
23.61
21.25
%
1.33
92
695
332
2892
1.23
2.38
4.0
3.7
—
—
—
0
0
72
505
1.46
2.35
1.4
1.3
168.00
208.15
u/ml
0.21
65
465
57
828
0.67
2.31
4.4
4.2
34.05
31.87
%
0.75
40
565
226
1895
1.26
2.27
3.8
3.3
634.38
231.70
mg/l
0.47
139
1229
7
18
3.91
2.25
1.4
2.7
—
—
—
0
0
29
164
1.79
2.25
1.1
1.2
73.52
32.38
u/ml
—
5
17
223
1872
1.25
2.22
1.7
1.6
1.30
1.37
mmol/l
0.53
191
1571
8
24
3.35
2.18
1.4
1.2
—
—
—
0
0
47
307
1.56
2.15
1.3
1.3
269.25
237.52
miu/ml
0.22
25
152
7
19
3.70
2.15
1.1
1.3
—
—
—
0
0
81
592
1.40
2.14
4.3
7.3
1.19
1.37
mmol/l
1.20
81
576
67
473
1.45
2.13
2.6
2.1
12.59
11.54
nmol/l
0.38
60
426
35
213
1.67
2.13
1.5
1.6
—
177.50
—
0
8
25
138
1.83
2.11
1.8
1.4
121.57
107.77
u/ml
—
7
26
10
37
2.72
2.07
1.5
1.4
15.80
14.19
u/l
—
10
32
12
50
2.42
2.03
1.4
1.2
—
—
—
0
0
236
2022
1.23
1.93
4.4
3.8
0.00
0.01
estimate
1.08
85
731
349
3107
1.20
1.93
15.6
12.7
1.22
1.22
inr
0.01
98
963
12
52
2.33
1.88
3.1
3.2
—
—
—
0
0
45
303
1.51
1.84
3.3
3.7
60.59
48.22
%
2.43
45
297
752
7214
1.26
1.81
4.4
4.1
4.64
4.68
mmol/l
0.41
714
6738
13
60
2.18
1.78
1.1
1.2
—
—
—
0
0
749
7186
1.25
1.77
4.3
4.1
1.49
1.48
mmol/l
0.27
707
6682
35
226
1.57
1.73
1.1
1.2
—
—
—
0
0
211
1807
1.22
1.72
1.3
1.3
0.82
1.73
u/ml
1.44
62
490
35
228
1.56
1.67
1.1
1.2
—
—
—
0
0
21
119
1.78
1.67
1.3
1.2
—
—
—
0
0
10
40
2.52
1.67
1.3
1.9
—
—
—
0
0
10
40
2.52
1.67
1.1
1.1
—
—
—
0
0
10
40
2.52
1.67
1.3
1.9
—
—
—
0
0
6
19
3.17
1.66
1.3
1.1
—
—
—
0
0
7
25
2.81
1.65
1.3
2.5
88.61
83.61
ug/l
—
7
25
762
7340
1.25
1.64
4.9
4.5
2.73
2.78
mmol/l
0.86
718
6818
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
44
2.29
1.56
1.1
1.2
—
—
—
0
0
7
27
2.60
1.51
1.4
1.5
15.46
13.28
pmol/l
—
7
22
16
86
1.88
1.51
1.0
1.1
—
—
—
0
0
172
1463
1.22
1.50
1.5
1.4
—
—
—
0
0
188
1616
1.21
1.48
3.7
3.8
1.02
1.02
kg/l
0.15
19
208
31
203
1.55
1.47
1.3
1.1
—
—
—
0
0
208
1806
1.20
1.47
5.9
5.0
2.20
3.16
ug/l
0.93
192
1614
44
311
1.44
1.46
3.2
3.3
24.88
25.10
mmol/l
0.16
44
302
20
117
1.73
1.46
1.1
1.1
—
—
—
0
0
21
339
0.61
1.44
1.2
1.8
4.66
3.14
mg/l
0.33
16
247
55
732
0.74
1.42
1.5
1.6
—
—
—
0
0
30
197
1.54
1.42
5.5
3.7
3.82
3.86
mmol/l
0.29
30
192
29
189
1.55
1.41
1.4
1.2
—
—
—
0
0
65
495
1.34
1.40
2.8
3.3
4.40
4.60
pmol/l
1.02
59
437
7
29
2.42
1.39
1.1
1.1
—
—
—
0
0
15
83
1.82
1.32
1.0
1.1
—
—
—
0
0
70
546
1.31
1.29
2.7
2.4
10.57
6.19
ug/l
0.31
64
485
9
44
2.06
1.27
1.6
1.4
—
21.00
—
0
7
9
44
2.06
1.27
1.1
1.4
—
—
—
0
0
226
2003
1.17
1.26
4.2
3.9
13.43
8.97
mg/mmol
0.40
140
1263
381
3512
1.15
1.25
3.2
2.8
127.02
108.28
ug/l
0.37
361
3258
182
1587
1.18
1.23
1.7
1.5
2.00
2.34
g/l
2.43
107
980
22
140
1.59
1.21
1.5
1.4
—
—
—
0
0
22
140
1.59
1.21
1.5
1.4
—
—
—
0
0
44
326
1.37
1.16
1.1
1.1
—
0.90
—
0
5
153
1321
1.19
1.16
1.3
1.3
19.87
30.88
iu/ml
1.72
46
427
72
574
1.28
1.15
1.7
1.7
—
—
—
0
0
100
829
1.23
1.15
8.3
6.6
—
—
—
0
0
36
259
1.41
1.13
1.3
1.3
—
—
—
0
0
28
192
1.47
1.12
1.4
1.2
4.05
10.42
u/ml
—
6
34
82
667
1.25
1.12
2.8
4.2
25.33
27.49
ug/l
0.04
62
550
715
6912
1.17
1.11
4.0
3.7
1.26
1.25
mmol/l
0.02
668
6392
7
32
2.20
1.08
1.0
1.0
—
—
—
0
0
183
1618
1.16
1.05
1.6
1.6
—
—
—
0
0
24
162
1.49
1.05
1.3
1.3
—
—
—
0
0
36
265
1.37
1.01
1.3
1.5
10.08
9.99
u/l
0.01
27
216
206
1844
1.15
1.01
3.2
3.0
1242.53
1191.68
ng/l
0.07
170
1564
44
335
1.33
1.00
5.5
10.2
24.57
24.47
mmol/l
0.06
44
327
55
433
1.29
0.99
1.3
1.4
20.97
26.37
iu/l
0.80
47
366
23
156
1.49
0.99
1.5
1.7
—
—
—
0
0
11
61
1.81
0.98
1.5
1.3
6.49
6.64
mmol/l
0.05
11
56
14
84
1.68
0.98
1.1
1.7
—
—
—
0
0
15
92
1.64
0.97
1.7
1.6
—
—
—
0
0
25
174
1.45
0.96
1.3
1.4
—
—
—
0
0
11
62
1.78
0.94
1.5
1.7
—
—
—
0
0
713
6923
1.15
0.90
15.6
11.8
82.43
84.61
ml/min/173m2
1.54
583
5639
6
29
2.08
0.89
1.5
2.6
—
—
—
0
0
27
194
1.40
0.89
1.3
1.2
—
—
—
0
0
32
237
1.36
0.89
5.5
3.9
1.31
1.39
mmol/l
0.23
32
231
40
307
1.32
0.88
1.3
1.5
—
—
—
0
0
8
42
1.91
0.88
1.1
1.0
—
—
—
0
0
56
450
1.26
0.88
1.1
1.0
—
—
—
0
0
234
2133
1.13
0.88
3.7
3.1
6.92
7.68
mmol/l
1.94
199
1803
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
195
1.40
0.87
4.6
2.9
0.28
0.38
u/ml
1.12
17
98
28
204
1.38
0.86
1.4
1.3
—
—
—
0
0
12
72
1.68
0.85
1.5
1.6
—
—
—
0
0
679
6582
1.13
0.84
5.7
5.3
38.45
39.27
mmol/mol
1.76
642
6128
34
258
1.33
0.82
3.6
3.6
92.12
1521.66
u/ml
1.26
25
224
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
6
32
1.88
0.82
1.2
1.4
—
—
—
0
0
6
32
1.88
0.82
3.7
1.6
21.67
32.09
umol/l
—
6
32
26
189
1.39
0.81
1.6
1.7
33.96
40.63
nmol/l
1.19
26
180
86
731
1.20
0.81
2.0
1.8
—
—
—
0
0
10
58
1.73
0.80
1.0
1.0
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
11
67
1.65
0.75
3.7
2.4
—
—
—
0
0
7
40
1.76
0.71
2.7
3.1
—
—
—
0
0
9
58
1.56
0.70
1.1
1.1
—
—
—
0
0
10
61
1.65
0.68
1.2
1.0
—
—
—
0
0
9
59
1.53
0.68
1.3
1.6
—
—
—
0
0
9
59
1.53
0.68
1.3
1.6
—
—
—
0
0
9
59
1.53
0.68
1.3
1.6
—
—
—
0
0
12
78
1.55
0.65
1.5
1.4
—
—
—
0
0
12
78
1.55
0.65
1.5
1.4
—
—
—
0
0
11
70
1.58
0.65
1.0
1.1
—
—
—
0
0
11
70
1.58
0.65
1.0
1.1
—
—
—
0
0
131
1455
0.88
0.64
1.6
1.7
439.05
28079246.14
pmol/l
1.57
108
1218
203
1873
1.11
0.63
2.6
2.1
2.71
2.96
mg/l
0.94
178
1598
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
6
105
0.57
0.62
1.3
1.4
8.10
7.20
mmol/l
—
6
86
51
426
1.21
0.61
2.2
2.2
3983.00
4362.23
u/l
0.06
19
176
5
30
1.67
0.61
1.0
1.1
435.20
1946.80
miu/ml
—
5
30
5
30
1.67
0.61
1.2
1.4
—
—
—
0
0
16
113
1.42
0.61
1.1
1.6
—
—
—
0
0
27
209
1.30
0.61
1.2
1.8
3.31
5.28
iu/l
—
8
74
8
51
1.57
0.60
1.6
1.5
7.89
8.62
u/l
—
8
41
8
53
1.51
0.58
1.4
1.5
0.82
1.01
g/l
—
8
53
65
559
1.18
0.58
6.3
3.9
1.22
1.23
mmol/l
0.45
56
483
21
158
1.34
0.57
1.8
1.7
—
—
—
0
0
52
439
1.20
0.57
1.2
1.3
—
—
—
0
0
22
167
1.33
0.57
1.1
1.1
0.57
2.96
u/ml
2.62
11
84
8
55
1.46
0.56
1.0
1.3
—
—
—
0
0
6
37
1.63
0.55
1.2
3.1
574.17
773.65
u/ml
—
6
37
16
116
1.39
0.54
2.1
1.7
—
—
—
0
0
6
39
1.54
0.53
1.0
1.4
—
47.14
—
0
7
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
10
66
1.52
0.52
5.1
3.7
—
—
—
0
0
9
63
1.43
0.52
1.3
1.5
—
—
—
0
0
21
161
1.31
0.52
1.7
1.6
—
—
—
0
0
9
64
1.41
0.51
1.2
1.3
—
—
—
0
0
9
64
1.41
0.51
1.7
1.5
1.33
1.41
nmol/l
—
9
57
9
65
1.39
0.50
1.2
1.3
—
—
—
0
0
6
41
1.47
0.50
1.3
1.8
—
—
—
0
0
14
101
1.39
0.49
1.1
1.6
—
—
—
0
0
16
119
1.35
0.48
1.1
1.1
—
—
—
0
0
12
85
1.42
0.47
1.2
1.6
—
—
—
0
0
138
1273
1.10
0.45
1.3
1.3
13.17
9.12
u/ml
0.33
50
498
7
50
1.40
0.45
1.6
1.9
—
—
—
0
0
15
112
1.35
0.45
1.7
1.5
—
—
—
0
0
15
112
1.35
0.45
1.7
1.5
—
—
—
0
0
21
166
1.27
0.43
1.6
1.3
—
—
—
0
0
25
203
1.24
0.42
2.0
3.0
—
—
—
0
0
5
32
1.57
0.42
1.4
2.0
—
—
—
0
0
5
33
1.52
0.41
1.4
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
14
105
1.34
0.41
1.0
1.1
—
—
—
0
0
47
408
1.16
0.41
1.6
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
28.72
—
0
18
8
61
1.31
0.39
1.4
1.8
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
113
1224
0.91
0.39
1.6
1.7
1243.49
1194.74
nmol/l
0.23
87
919
20
161
1.25
0.37
3.9
2.4
75.41
112.31
ug/min
0.33
11
101
36
309
1.17
0.37
1.6
1.8
—
—
—
0
0
510
4977
1.06
0.35
3.3
3.0
45.04
44.11
u/l
0.09
482
4682
45
396
1.14
0.34
1.4
1.4
—
—
—
0
0
6
45
1.34
0.33
1.0
1.1
80.80
93.68
u/l
—
6
45
6
45
1.34
0.33
1.0
1.1
34.32
28.34
u/l
—
6
45
6
86
0.70
0.33
1.0
1.2
—
—
—
0
0
10
74
1.36
0.32
1.9
1.7
—
—
—
0
0
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
11
141
0.78
0.29
2.1
2.0
0.63
0.87
nmol/l
1.60
11
118
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
18
215
0.83
0.27
1.2
1.5
—
—
—
0
0
46
416
1.11
0.25
4.7
3.7
0.92
1.65
mmol/l
0.68
35
312
9
77
1.17
0.24
4.7
3.4
29.93
56.88
u/ml
—
9
77
18
153
1.18
0.22
1.3
1.5
—
—
—
0
0
17
144
1.18
0.22
1.2
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.5
1.50
1.56
g/l
—
5
41
118
1241
0.94
0.22
2.1
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
10
0.00
0.21
0.0
5.1
—
8.09
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
88
933
0.94
0.21
1.6
1.7
1.46
1.43
%
0.12
81
835
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
10
81
1.24
0.19
1.0
1.2
—
—
—
0
0
22
194
1.14
0.18
1.8
1.6
—
—
—
0
0
24
268
0.89
0.17
2.8
1.9
—
—
—
0
0
58
616
0.94
0.15
1.3
1.2
46.70
162.16
iu/ml
6.23
21
244
15
130
1.16
0.15
1.1
1.1
—
12.03
—
0
11
15
130
1.16
0.15
1.3
1.2
—
—
—
0
0
18
160
1.13
0.14
1.8
1.3
287.92
257.38
u/ml
0.11
12
97
8
99
0.81
0.13
1.0
1.1
1.41
1.47
g/l
—
8
90
13
113
1.15
0.13
1.2
3.9
76.22
63.66
%
1.46
13
113
10
117
0.85
0.13
1.1
1.1
—
—
—
0
0
38
355
1.07
0.12
1.4
1.5
—
—
—
0
0
16
143
1.12
0.11
1.1
1.1
0.56
1.84
u/ml
0.95
11
71
23
250
0.92
0.11
1.5
1.7
—
—
—
0
0
41
387
1.06
0.11
2.0
1.6
—
—
—
0
0
253
2574
0.98
0.10
3.5
3.5
32.20
50.88
ng/l
0.62
160
1673
23
249
0.92
0.10
2.7
1.7
—
—
—
0
0
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
35
330
1.06
0.09
1.4
1.4
—
—
—
0
0
5
47
1.06
0.09
1.4
1.7
—
—
—
0
0
74
714
1.04
0.09
3.7
3.2
—
—
—
0
0
33
311
1.06
0.09
1.6
1.7
—
—
—
0
0
11
97
1.14
0.09
1.5
1.3
—
—
—
0
0
35
331
1.06
0.09
1.4
1.4
—
—
—
0
0
35
331
1.06
0.09
1.4
1.4
—
—
—
0
0
5
61
0.82
0.08
1.6
2.3
—
—
—
0
0
35
332
1.06
0.08
1.4
1.4
—
—
—
0
0
7
65
1.08
0.08
1.9
1.3
—
—
—
0
0
17
156
1.09
0.08
1.1
1.1
—
—
—
0
0
22
205
1.08
0.08
1.7
1.4
319.73
302.58
ug/g
0.20
15
114
9
87
1.03
0.07
2.2
2.2
—
—
—
0
0
8
90
0.89
0.06
1.1
1.3
—
—
—
0
0
8
92
0.87
0.06
1.0
1.0
—
—
—
0
0
11
99
1.11
0.06
1.5
1.3
—
—
—
0
0
11
99
1.11
0.06
1.5
1.3
—
—
—
0
0
17
160
1.06
0.04
2.1
2.4
130.08
130.60
g/l
0.03
12
120
59
601
0.98
0.02
1.4
1.5
—
—
—
0
0
12
128
0.94
0.02
1.2
1.0
0.69
1.91
u/ml
—
7
60
15
142
1.06
0.02
3.3
2.5
16.14
16.35
%
—
7
72
25
243
1.03
0.01
1.4
2.0
—
—
—
0
0
111
1118
0.99
0.01
2.0
2.0
—
—
—
0
0
29
284
1.02
0.00
1.3
1.6
—
—
—
0
0
19
186
1.02
0.00
3.4
3.1
8.88
8.38
kpa
0.52
19
181
10
98
1.02
0.00
1.6
1.3
—
—
—
0
0
10
97
1.03
0.00
1.6
1.3
—
—
—
0
0
10
97
1.03
0.00
1.6
1.3
—
—
—
0
0
14
137
1.02
0.00
1.4
1.8
—
—
—
0
0
16
155
1.03
0.00
2.8
3.9
23.47
26.87
mg/l
0.21
11
97
0
7
0.00
-0.00
0.0
1.1
—
7.00
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
88
0.91
-0.00
1.9
2.6
107.38
105.49
mmol/l
—
8
88
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.8
1.1
—
79.00
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
73
0.96
-0.00
2.1
2.1
20.71
24.96
nmol/l
—
7
68
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.4
274372.00
121634.18
e6/l
—
5
44
9
96
0.94
-0.00
1.6
1.3
0.96
0.52
nmol/l
—
9
89
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MELANOCYTIC_UPPERLIMB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_UPPERLIMB | 0.956 [0.77, 1.18] | 0.675 |
| Birth year | 0.993 [0.98, 1.0] | 0.108 |
During the follow-up period (1.1.1998 — 31.12.2019), 141 out of 2628 females with CD2_BENIGN_MELANOCYTIC_UPPERLIMB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_UPPERLIMB | 1.079 [0.87, 1.33] | 0.484 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 195 out of 1808 males with CD2_BENIGN_MELANOCYTIC_UPPERLIMB died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MELANOCYTIC_UPPERLIMB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.078% | 0.197% |
| 5 | 0.423% | 1.251% |
| 10 | 1.2% | 3.089% |
| 15 | 2.353% | 6.013% |
| 20 | 4.284% | 10.315% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_UPPERLIMB – Melanocytic naevi of upper limb, including shoulder
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data